Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference
27 nov. 2017 16h10 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in investor...
New Study Published in PLOS ONE Advances Science Around VTS-270 for Treatment of Niemann-Pick Disease Type C1
18 avr. 2017 06h30 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., April 18, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the publication of a new study in an...